These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 29871275)
1. [Polymorphism analysis of MTHFR,BMPR1B and TYMS in microtia]. Liu N; Liu YF; Sui J; Zhang YQ; Ma SM; Wu WJ; Liang G; Tan Q Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(6):409-414. PubMed ID: 29871275 [No Abstract] [Full Text] [Related]
2. Genotype and allele frequencies of TYMS rs2790 A > G polymorphism in a Chinese paediatric population with acute lymphoblastic leukaemia. Wang SM; Zeng WX; Wu WS; Sun LL; Yan D J Clin Pharm Ther; 2018 Aug; 43(4):507-512. PubMed ID: 29500934 [TBL] [Abstract][Full Text] [Related]
3. The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence. Cavic M; Krivokuca A; Spasic J; Brotto K; Malisic E; Radosavljevic D; Radulovic S; Jankovic R J BUON; 2014; 19(4):1024-8. PubMed ID: 25536611 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer. Lin S; Yue J; Guan X; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B Cancer Commun (Lond); 2019 Oct; 39(1):57. PubMed ID: 31601265 [TBL] [Abstract][Full Text] [Related]
5. Interactions of 5'-UTR thymidylate synthase polymorphism with 677C → T methylene tetrahydrofolate reductase and 66A → G methyltetrahydrofolate homocysteine methyl-transferase reductase polymorphisms determine susceptibility to coronary artery disease. Vijaya Lakshmi SV; Naushad SM; Rupasree Y; Seshagiri Rao D; Kutala VK J Atheroscler Thromb; 2011; 18(1):56-64. PubMed ID: 20962453 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic study of methylenetetrahydrofolate reductase and thymidylate synthase in Japanese and assessment of ethnic and gender differences. Inoue S; Hashiguchi M; Chiyoda T; Sunami Y; Tanaka T; Mochizuki M Pharmacogenomics; 2007 Jan; 8(1):41-7. PubMed ID: 17187508 [TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Yuan JM; Lu SC; Van Den Berg D; Govindarajan S; Zhang ZQ; Mato JM; Yu MC Hepatology; 2007 Sep; 46(3):749-58. PubMed ID: 17659576 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Lima CS; Ortega MM; Ozelo MC; Araujo RC; De Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; Costa FF Leuk Res; 2008 Mar; 32(3):401-5. PubMed ID: 17655928 [TBL] [Abstract][Full Text] [Related]
10. Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China. Cui LH; Song Y; Si H; Shen F; Shin MH; Kim HN; Choi JS Med Oncol; 2012 Sep; 29(3):1837-42. PubMed ID: 21956592 [TBL] [Abstract][Full Text] [Related]
11. Association study of the common polymorphisms in the folate-methionine pathway with retinoblastoma. Soleimani E; Saliminejad K; Akbari MT; Kamali K; Ahani A Ophthalmic Genet; 2016 Dec; 37(4):384-387. PubMed ID: 26914443 [TBL] [Abstract][Full Text] [Related]
12. Association of MTHFR and TYMS gene polymorphisms with the susceptibility to HCC in Egyptian HCV cirrhotic patients. Abdel Allah HMM; Zahran WE; El-Masry SA; El-Bendary M; Soliman AF Clin Exp Med; 2022 May; 22(2):257-267. PubMed ID: 34297238 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in folate metabolism genes are associated with susceptibility to presbycusis. Manche SK; Jangala M; Dudekula D; Koralla M; Akka J Life Sci; 2018 Mar; 196():77-83. PubMed ID: 29369772 [TBL] [Abstract][Full Text] [Related]
14. Rs4846049 Polymorphism at the 3'-UTR of MTHFR Gene: Association with Susceptibility to Childhood Acute Lymphoblastic Leukemia. Li X; Zhang S; Yu F Biomed Res Int; 2019; 2019():4631091. PubMed ID: 31737664 [TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients. Sharma R; Hoskins JM; Rivory LP; Zucknick M; London R; Liddle C; Clarke SJ Clin Cancer Res; 2008 Feb; 14(3):817-25. PubMed ID: 18245544 [TBL] [Abstract][Full Text] [Related]
16. Investigation of Cevik M; Namal E; Sener ND; Koksal UI; Cagatay P; Deliorman G; Ciftci C; Karaalp A; Susleyici B Per Med; 2022 Sep; 19(5):435-444. PubMed ID: 35880438 [TBL] [Abstract][Full Text] [Related]
17. Influence of polymorphisms in MTHFR 677 C→T, TYMS 3R→2R and MTR 2756 A→G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC. Cui LH; Yu Z; Zhang TT; Shin MH; Kim HN; Choi JS Pharmacogenomics; 2011 Jun; 12(6):797-808. PubMed ID: 21605004 [TBL] [Abstract][Full Text] [Related]
18. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis. Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563 [TBL] [Abstract][Full Text] [Related]
19. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Justenhoven C; Hamann U; Pierl CB; Rabstein S; Pesch B; Harth V; Baisch C; Vollmert C; Illig T; Brüning T; Ko Y; Brauch H Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):3015-8. PubMed ID: 16365030 [No Abstract] [Full Text] [Related]
20. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults. Liu P; Zhang M; Xie X; Jin J; Holman CD Tumour Biol; 2016 Mar; 37(3):3265-75. PubMed ID: 26438060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]